Patents by Inventor Guy BAUDOUX

Guy BAUDOUX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic rhinovirus peptides
    Patent number: 10493145
    Abstract: Fusion proteins comprising a carrier protein and a Human Rhinovirus (HRV) peptide, and immunogenic compositions containing such fusion proteins.
    Type: Grant
    Filed: August 17, 2018
    Date of Patent: December 3, 2019
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: Guy Baudoux, Mathieu Boxus, Brigitte Colau, Martine Marchand
  • IMMUNOGENIC RHINOVIRUS PEPTIDES
    Publication number: 20190076519
    Abstract: Fusion proteins comprising a carrier protein and a Human Rhinovirus (HRV) peptide, and immunogenic compositions containing such fusion proteins.
    Type: Application
    Filed: August 17, 2018
    Publication date: March 14, 2019
    Applicant: GlaxoSmithKline Biologicals S.A.
    Inventors: Guy BAUDOUX, Mathieu BOXUS, Brigitte COLAU, Martine MARCHAND
  • Vaccine
    Patent number: 10058603
    Abstract: The disclosure provides immunogenic compositions comprising human picornavirus peptides derived from structural proteins of the virus, constructs comprising the peptides, the peptides themselves and their use in the prevention of picornavirus infection and disease. Particular peptides from VP4 and VP1 are disclosed.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: August 28, 2018
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Guy Baudoux, Mathieu Boxus, Brigitte Colau, Martine Marchand
  • VACCINE
    Publication number: 20160022803
    Abstract: The disclosure provides immunogenic compositions comprising human picornavirus peptides derived from structural proteins of the virus, constructs comprising the peptides, the peptides themselves and their use in the prevention of picornavirus infection and disease. Particular peptides from VP4 and VP1 are disclosed.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 28, 2016
    Inventors: Guy BAUDOUX, Mathieu BOXUS, Brigitte COLAU, Martine MARCHAND